Atossa Genetics Inc Share Price Nasdaq
Equities
US04962H2094
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 194M 15.38B |
---|---|---|---|---|---|
Net income 2024 * | -31M -2.46B | Net income 2025 * | -39M -3.1B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.42
x | P/E ratio 2025 * |
-5.31
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Genetics Inc
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 30/11/08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 30/11/08 |
Heather Rees
DFI | Director of Finance/CFO | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 30/11/08 |
Director/Board Member | 66 | 28/02/14 | |
H. Remmel
BRD | Director/Board Member | 72 | 31/01/12 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |